Related Experiment Video
Updated: Nov 3, 2025

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
Published on: May 23, 2025
Locked Away-Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
Joanna Szymańska1, Katarzyna Kakareko1, Alicja Rydzewska-Rosołowska1
12nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, 15-276 Białystok, Poland.
Insights
Citrate 4% is a cost-effective and safe locking solution for hemodialysis catheters, preventing thrombosis and infection. Alternative protocols like taurolidine with urokinase show promise but require further research for catheter dysfunction management.
Area of Science:
- Nephrology
- Vascular Access Management
- Infectious Disease Prevention
Background:
- Hemodialysis requires reliable vascular access, with arteriovenous fistulas (AVFs) preferred.
- Permanent central venous catheters (CVCs) are used when AVFs are not feasible or for short-term dialysis.
- CVCs are associated with thrombosis and catheter-related bloodstream infections (CRBSIs), risking access loss.
Purpose of the Study:
- To review available locking solutions for dialysis catheters.
- To evaluate their effectiveness in preventing thrombotic and infectious complications.
- To discuss management strategies for CVC dysfunction.
Main Methods:
- Systematic search of the PubMed database for relevant articles.
- Inclusion of studies on end-stage kidney disease patients using permanent CVCs.
- Extraction of data on thrombotic and infectious complications of CVC use.
Main Results:
- Citrate (4%) demonstrates a favorable cost-effectiveness and safety profile, aligning with international guidelines.
- Emerging evidence suggests taurolidine-based solutions with urokinase may offer advantages, warranting further investigation.
- Prophylactic thrombolytic agent use should commence early to mitigate thrombotic risks.
Conclusions:
- Citrate 4% is a recommended locking solution for hemodialysis CVCs.
- Further research is needed to validate newer protocols like taurolidine-based solutions.
- Prompt catheter replacement is advised for persistent CVC dysfunction, regardless of thrombolysis attempts.
Abstract:
Reliable vascular access is necessary for effective hemodialysis. Guidelines recommend chronic hemodialysis via an arteriovenous fistula (AVF), however, in a significant number of patients, permanent central venous catheters (CVCs) are used. The use of a tunneled catheter is acceptable if the estimated dialysis time is less than a year or it is not possible to create an AVF. The main complications associated with CVC include thrombosis and catheter-related bloodstream infections (CRBSIs), which may result in loss of vascular access. The common practice is to use locking solutions to maintain catheter patency and minimize the risk of CRBSI. This paperwork summarizes information on currently available locking solutions for dialysis catheters along with their effectiveness in preventing thrombotic and infectious complications and describes methods of dealing with catheter dysfunction. The PubMed database was systematically searched for articles about locking solutions used in permanent CVCs in hemodialysis patients. Additional studies were identified by searching bibliographies and international guidelines. Articles on end-stage kidney disease patients dialyzed through a permanent CVC were included. Information from each primary study was extracted using pre-determined criteria including thrombotic and infectious complications of CVC use, focusing on permanent CVC if sufficient data were available. Of the currently available substances, it seems that citrate at a concentration of 4% has the best cost-effectiveness and safety profile, which is reflected in the international guidelines. Recent studies suggest the advantage of 2+1 protocols, i.e., taurolidine-based solutions with addition of urokinase once a week, although it needs to be confirmed by further research. Regardless of the type of locking solution, if prophylaxis with a thrombolytic agent is chosen, it should be started from the very beginning to reduce the risk of thrombotic complications. In case of CVC dysfunction, irrespective of the thrombolysis attempt, catheter replacement should be planned as soon as possible.
Related Concept Videos
Hemodialysis III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Cardiac Catheterization IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization I: Pre-Procedure Overview

